Answers are grounded in this paper and cite their sources.
Alafosfalin, an antibacterial phosphonodipeptide requiring peptide transport for activity, was tested for activity against clinical strains of anaerobic bacteria in peptide-free Roche Sensitivity Test Medium no. 5 agar. It was active against Bacteroides spp., Fusobacterium nucleatum, and Clostridium perfringens but not against Clostridium difficile. Alafosfalin activity was antagonized by appropriate peptides. Synergy was obtained with other cell wall-active antibiotics.
No takes yet. Share an insight, caveat, or question.
Grappel et al. (1985) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: